Liberol / TRH researchЛиберол
What is it?
An archival occupational-research record for the Liberol/TRH branch, covering historical human functional-reserve experiments.
Research context
An archival occupational-research record for the Liberol/TRH branch, covering historical human functional-reserve experiments.
What the studies found
No study findings are ready to summarize for this preparation. Linked archival leads still need original-source verification; this is not evidence that no research exists.
- Working classification
- Peptide research family
- Research collection
- Neuropeptide research · editorial grouping
- Institutional provenance
- Not established for this compound record
- Last evidence review
- Full evidence review pending; source-check scope appears with each publication below.
What do we know?
- Human research
- —Human dissertation material; original scan and study design pending
- Study methods
- —Member-specific studies; patents and archival leads identified separately
- Independent replication
- —Independent replication not established by the records collected here
- Source access
- —Primary abstracts, selected full texts, patents and explicit retrieval targets
- Safety evidence
- —Cell and animal effects do not establish human safety; analogues may differ
These are independent review fields, not a rating. Missing evidence in this starter does not mean no research exists.
Inside this research family
Grouping supports navigation. It does not imply equivalent composition, mechanisms, effectiveness or safety.
| Member | Identity | What the source supports |
|---|---|---|
| Liberol | TRH/protirelin identification trail | The dissertation identifies Liberol as thyroliberin/TRH, pGlu–His–Pro–NH₂; formulation details still need original-scan review. |
| Occupational experiments | Hypoxia, motion stress and performance | Human dissertation material; allocation and full numerical tables remain under review. |
Interpretation and open questions
Historical functional-reserve experiments do not establish protection during real-world altitude exposure or dangerous work.
Linked sources
Explore the research map and unresolved leads ↗
Use of the peptide bioregulator Liberol to restore human functional reserves under extreme exposures
S. V. Padalko · Primary source linked above
Padalko identifies Liberol as thyroliberin/TRH (pyroglutamyl-His-Pro-amide) and reports human hypoxia, motion-stress and performance experiments. Cohort structure and numerical results require the original scan.
- Population / setting
- Human occupational experiments; dissertation transcription
- What was checked
- Selected original-source text checked; full methodological review pending.
Limitations & review scope
- Original scan, formulation and allocation require verification.
- Not a modern controlled trial or evidence supporting unsupervised altitude use.
Source checked 2026-10-05. This is a source-linked record, not a completed evidence review.